Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in INKT — MiNK Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to INKT Full portfolio

Position in INKT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$182,047
-$594 QoQ
Shares Held
15,573
-10.2% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 27 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. INKT ranks #407 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in INKT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $182,047 15,573
2026-03-31 $182,641 17,345
2025-12-31 $158,853 14,247
2025-09-30 $179,284 12,806
2025-06-30 $84,902 11,492
2025-03-31 $97,234 11,254
2024-12-31 $66,989 96,113
2024-09-30 $73,485 97,981
2024-06-30 $91,432 96,347
2024-03-31 $80,681 88,856
2023-12-31 $96,475 90,164
2023-09-30 $99,180 90,164
2023-06-30 $194,718 92,723
2023-03-31 $47,934 25,295
2022-12-31 $66,019 25,295
2022-09-30 $48,899 23,175
2022-06-30 $32,676 23,175
2022-03-31 $76,284 33,904
2021-12-31 $105,144 23,575